6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab
Clinical trial NCT00826267 · COMPLETED
Trial details
- NCT number
- NCT00826267
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2011-08-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.